Skip to main content
. 2022 Aug 5;22:856. doi: 10.1186/s12885-022-09971-w

Table 4.

Clinicopathological characteristics of patients with RCC with and without recurrence

Variables With recurrence (n = 5) Without recurrence (n = 118) P-value
Sex (Male/Female) 5/0 95/23 0.3484
Age (years); median (IQR) 65 (60–72) 64 (53–70) 0.5642
Age (≦60 vs 60 < years) 1/4 50/68 0.4017
BMI (kg/m2); median (IQR) 24.5 (21.5–28.3) 24.1 (21.2–26.7) 0.8177
ECOG PS (0/≥1) 5/0 111/7 1.0000
Charlson comorbidity index (0/≥1) 5/0 94/24 1.0000
Tumor size (mm); median (IQR) 30 (20–36) 26 (20–33) 0.5766
Tumor size (≦ 2 cm vs > 2 cm) 1/4 25/93 1.0000
Tumor location
 Right/Left 3/2 51/67 0.3849
 Posterior/anterior 4/1 45/73 0.0814
 Lateral/Medial 3/2 73/45 0.7163
Exophytic/Endophytic 5/0 111/7 1.0000
Tumor shape (Round/Non-round) 1/4 54/64 0.3790
Homogeneity/ Heterogeneity 0/5 26/92 0.2983
CV (+/−) 5/0 51/67 *0.0177
Surgical method (Partial/Radical) 5/0 103/15 0.5159
Histological type (CCC/non-CCC) 5/0 100/18 0.4469
pT stage (1a/ 3a) 4/1 105/13 0.4593
Fuhrman grade (1,2/ 3,4) 3/2 95/23 0.2678
INF (α/β,γ) 2/3 88/30 0.1193
Central necrosis (+/−) 1/4 25/93 0.7017
MVI (+/−) 3/2 50/68 0.3700
Surgical margin (+/−) 0/5 3/115 1.0000

IQR Interquartile range, BMI Body mass index, ECOG PS Eastern Cooperative Oncology Group Performance Status, CV Collateral vessel, CCC Clear cell carcinoma, INF Infiltrative growth, MVI microvascular invasion *p < 0.05